Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ferric Subsulfate Solution
2. Monsel's Solution
1. 1310-45-8
2. Ferric Subsulfate Solution
3. Basic Ferric Sulfate
4. Iron Hydroxide Sulfate (fe4(oh)2(so4)5)
5. Iron(3+);dihydroxide;pentasulfate
6. 3qj8ws6v8h
7. Monsel's Solution
8. Iron Dihydroxide Pentakis(sulphate)
9. Einecs 215-179-2
10. Unii-3qj8ws6v8h
11. Ferric Subsulfate [usp:nf]
12. Iron Hydroxide Sulfate
13. Iron Subsulfate
14. Ferric Subsulphate
15. Ferric Subsulfate (usp)
16. Basic Ferric Sulfate Solution
17. Monsel's Solution [mi]
18. Dtxsid30893846
19. Ferric Subsulfate [vandf]
20. Ferric Subsulphate Solution
21. Ferric Subsulfate [who-dd]
22. Ferric Subsulfate Decahydrate
23. Basic Ferric Sulphate Solution
24. Akos015910508
25. Ferric Subsulfate [usp Impurity]
26. Iron Dihydroxide Pentakis Sulfate
27. Iron(iii) Dihydroxide Pentakis(sulfate)
28. Iron Dihydroxide Pentakis Sulphate
29. Ft-0717042
30. D08921
31. Iron Hydroxide Sulphate (fe4(oh)2(so4)5)
32. Q5445335
Molecular Weight | 737.7 g/mol |
---|---|
Molecular Formula | Fe4H2O22S5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 0 |
Exact Mass | 737.50387 g/mol |
Monoisotopic Mass | 737.50387 g/mol |
Topological Polar Surface Area | 445 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 62.2 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 11 |
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
Related Excipient Companies
Excipients by Applications
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?